about
A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophreniaValproate for acute mood episodes in bipolar disorderRisperidone (depot) for schizophreniaAntiglucocorticoid and related treatments for psychosisClozapine for psychotic disorders in adults with intellectual disabilitiesAsenapine versus placebo for schizophreniaAtypical antipsychotics for psychosis in adolescentsManagement of sexual dysfunction due to antipsychotic drug therapyMaintenance treatment with antipsychotic drugs for schizophreniaAripiprazole versus other atypical antipsychotics for schizophreniaAripiprazole versus other atypical antipsychotics for schizophreniaQuetiapine versus other atypical antipsychotics for schizophreniaHaloperidol versus placebo for schizophreniaPaliperidone palmitate for schizophreniaHaloperidol for psychosis-induced aggression or agitation (rapid tranquillisation)Acetylcholinesterase inhibitors for schizophreniaRisperidone versus other atypical antipsychotics for schizophreniaEarly intervention for psychosisClozapine versus other atypical antipsychotics for schizophreniaOlanzapine versus other atypical antipsychotics for schizophreniaAripiprazole versus other atypical antipsychotics for schizophreniaClozapine combined with different antipsychotic drugs for treatment resistant schizophreniaZiprasidone versus other atypical antipsychotics for schizophreniaQuetiapine versus other atypical antipsychotics for schizophreniaRisperidone versus placebo for schizophreniaSertindole versus other atypical antipsychotics for schizophreniaHaloperidol plus promethazine for psychosis-induced aggressionOral paliperidone for schizophreniaInterventions to reduce weight gain in schizophreniaEarly Intervention for psychosisOlanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnessesOlanzapine for schizophreniaHaloperidol plus promethazine for psychosis-induced aggressionRisperidone versus olanzapine for schizophreniaSertindole for schizophreniaQuetiapine for schizophreniaNew generation antipsychotics for first episode schizophreniaHostility in schizophrenia: An integrated analysis of the combined Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and the European First Episode Schizophrenia Trial (EUFEST) studiesDevelopment and Psychometric Evaluation of the Treatment-Emergent Activation and Suicidality Assessment ProfileA double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD)
P2860
Q21260310-E9AB704F-BA7A-4401-B98C-8430A8035D6CQ22252976-D689405D-39ED-4EFF-B501-A96F7C2ECCC6Q24185901-65E7F906-DCF2-44D6-9FF3-926F9BE02945Q24186594-F1D53795-2870-4FA3-AE85-26DCE3AEA5E7Q24187048-707F51E2-7B3A-4E91-BE36-FEFB1FF3341AQ24187667-299B49A7-24A6-4E6A-9525-E37913FA85A9Q24197475-D8E2C49B-2B18-44F8-9372-01D842A429B3Q24197558-8E9FC193-86DB-4683-B494-649F9F44DE47Q24197902-2073981A-15CC-401A-A3CF-EAC8B5647D8FQ24200904-0C0E8D91-1063-4C67-932E-A9DE84E78C19Q24201232-B865D5C6-527C-47CC-B987-7033841279F6Q24202427-0C931B42-5803-47B8-A5BC-37024772AF21Q24202457-5805C339-BBDD-48D6-ACC4-FF0E2B331AFFQ24202846-2708B726-7F58-46EF-A901-4EEFFFFC2B7AQ24203034-A7CD7577-F8CD-40A0-A911-FCAB02E3A42AQ24203876-7481ACDB-646E-4AC4-AA2A-C64562549A37Q24234950-8B3F4B78-8564-4360-8E68-81A83A36B1D7Q24236296-8560C4BE-CDFE-46AC-8497-D6AACEC01B2AQ24236422-D06443BD-06FC-42F6-A24C-238DE15F1871Q24236545-650AC04F-75C9-48AE-83D2-E9764ED6A26AQ24240020-742239E9-37D1-41E8-9210-A574AA5469C8Q24240093-6229E7D6-6174-4187-B155-41AD6C26A2F9Q24240260-EAAFE06D-C616-4645-863E-C21E768A8852Q24240989-009089AC-C2F1-4054-A327-4F08863B6E02Q24241041-952B68F7-577E-4EA9-98FB-FF99A642F080Q24241594-FE5CBC36-B28E-4491-B9B1-819AA552CE02Q24241801-F35DDF6E-B086-47BB-8CFE-87A4E54C1464Q24242948-300A4E8C-AB1E-4D75-9934-B6C93E47A783Q24243093-794C9DA2-8545-446D-B13B-0B6642A9D0ABQ24243986-68DBE85E-5AB6-46B5-A0DD-F2E457CCB73FQ24244015-EC9D6D57-410B-42D7-8D81-CD8C078A71D9Q24244031-9EC92598-C9A6-4E9B-8D1F-09CE5B3CBCC9Q24245745-0B094A98-C780-4146-8B93-7F63FB3D0B84Q24246232-1DC1AAFE-11C1-434A-A103-88EA5ABA94E9Q24246531-FF776E39-078A-450C-AA08-B128224692AEQ24247154-AE28AB50-6F18-4B56-9A97-77BBC78F018DQ24247720-415EDDA5-7AC1-4B5E-9B73-17B6744A4AA5Q24289439-6460B411-D2E9-4E54-8F21-558545AE25FCQ24623483-01C947E9-2627-409E-9AE9-F878076B923EQ24624661-0FF903D2-E011-4A12-9990-B5BB7612B548
P2860
description
1989 nî lūn-bûn
@nan
1989 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
A rating scale for drug-induced akathisia
@ast
A rating scale for drug-induced akathisia
@en
A rating scale for drug-induced akathisia
@nl
type
label
A rating scale for drug-induced akathisia
@ast
A rating scale for drug-induced akathisia
@en
A rating scale for drug-induced akathisia
@nl
prefLabel
A rating scale for drug-induced akathisia
@ast
A rating scale for drug-induced akathisia
@en
A rating scale for drug-induced akathisia
@nl
P3181
P356
P1476
A rating scale for drug-induced akathisia
@en
P2093
T R Barnes
P3181
P356
10.1192/BJP.154.5.672
P407
P577
1989-05-01T00:00:00Z